ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / FundiShares S&P 500 EUR Hedged UCITS ETF (Acc)
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerIBCF(EUR) F
ETF TickerIUES.AS(EUR) CXE
ETF TickerIUSE.L(EUR) CXE
ETF TickerIUSE.MI(EUR) CXE
ETF TickerIUSEz(EUR) CXE
ETF TickerIUSE(EUR) ETF Plus

Holdings detail for INCY

Stock NameIncyte Corporation
TickerINCY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45337C1027
LEI549300Z4WN6JVZ3T4680

Show aggregate INCY holdings

News associated with INCY

Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $84.18, changing hands for $84.80/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-09-18 08:17:02
Incyte Reports Encouraging 24-Week Results From Phase 3 STOP-HS Program Of Povorcitinib
(RTTNews) - Incyte Corporation (INCY) on Wednesday announced encouraging 24-week data from the pivotal Phase 3 STOP-HS program evaluating povorcitinib in adults with hidradenitis suppurativa (HS). - 2025-09-17 03:26:09
Incyte Corporation (NASDAQ:INCY) Short Interest Update
Incyte Corporation (NASDAQ:INCY – Get Free Report) was the recipient of a significant increase in short interest during the month of August. As of August 15th, there was short interest totaling 9,600,000 shares, an increase of 29.4% from the July 31st total of 7,420,000 shares. Based on an average trading volume of 1,860,000 shares, the […] - 2025-09-11 04:51:36
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Incyte Corporation (NASDAQ:INCY – Get Free Report) has been assigned a consensus recommendation of “Hold” from the eighteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating on the company. The […] - 2025-08-26 02:32:54
Incyte (NASDAQ:INCY) Given New $73.00 Price Target at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Free Report) had its price objective increased by JPMorgan Chase & Co. from $67.00 to $73.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. A number of other research firms also recently commented on INCY. Citigroup upped their price objective on […] - 2025-08-25 03:08:46
LABU, INCY, UTHR, REGN: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Charles Schwab Investment Management Inc. Purchases 38,962 Shares of Incyte Corporation (NASDAQ:INCY)
Charles Schwab Investment Management Inc. raised its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,682,029 shares of the biopharmaceutical company’s stock after purchasing an additional 38,962 […] - 2025-08-13 05:43:01
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Citigroup Raises Incyte (NASDAQ:INCY) Price Target to $103.00
Incyte (NASDAQ:INCY – Get Free Report) had its price objective lifted by equities researchers at Citigroup from $88.00 to $103.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Citigroup’s target price suggests a potential upside of 37.54% from the […] - 2025-08-01 04:32:55
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Incyte Corporation (NASDAQ:INCY – Get Free Report) have earned a consensus rating of “Hold” from the eighteen research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and five have assigned a buy recommendation to the […] - 2025-08-01 03:04:43
Incyte Reaches Analyst Target Price
In recent trading, shares of Incyte Corporation (Symbol: INCY) have crossed above the average analyst 12-month target price of $76.09, changing hands for $77.38/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v - 2025-07-30 10:12:59
Mutual of America Capital Management LLC Sells 478 Shares of Incyte Corporation (NASDAQ:INCY)
Mutual of America Capital Management LLC lessened its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,719 shares of the biopharmaceutical company’s stock after selling 478 shares during the quarter. […] - 2025-07-22 08:02:58
Incyte Corporation (NASDAQ:INCY) Shares Sold by Ballentine Partners LLC
Ballentine Partners LLC trimmed its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 12.2% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 4,686 shares of the biopharmaceutical company’s stock after selling 649 shares during the quarter. Ballentine Partners LLC’s holdings in Incyte were worth $284,000 at the end of the most recent […] - 2025-07-17 05:12:56
Cerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)
Cerity Partners LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 103.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 132,703 shares of the biopharmaceutical company’s stock after buying an additional 67,495 shares during the period. Cerity Partners LLC owned […] - 2025-07-16 05:40:51
Incyte (NASDAQ:INCY) Price Target Cut to $67.00 by Analysts at JPMorgan Chase & Co.
Incyte (NASDAQ:INCY – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $68.00 to $67.00 in a report released on Monday,Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of […] - 2025-07-16 04:26:52
Sheila A. Denton Sells 599 Shares of Incyte Corporation (NASDAQ:INCY) Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Sheila A. Denton sold 599 shares of the company’s stock in a transaction that occurred on Wednesday, July 2nd. The shares were sold at an average price of $68.61, for a total value of $41,097.39. Following the completion of the sale, the executive vice president owned 26,504 […] - 2025-07-09 06:12:52
Incyte Corporation (NASDAQ:INCY) EVP Barry P. Flannelly Sells 10,903 Shares of Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Barry P. Flannelly sold 10,903 shares of the stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $68.15, for a total transaction of $743,039.45. Following the sale, the executive vice president directly owned 39,744 shares of the […] - 2025-07-08 06:54:44
Incyte Corporation (NASDAQ:INCY) EVP Sells $587,248.55 in Stock
Incyte Corporation (NASDAQ:INCY – Get Free Report) EVP Vijay K. Iyengar sold 8,617 shares of the company’s stock in a transaction dated Thursday, July 3rd. The stock was sold at an average price of $68.15, for a total transaction of $587,248.55. Following the completion of the sale, the executive vice president directly owned 37,701 shares […] - 2025-07-08 06:20:54
Incyte Corporation (NASDAQ:INCY) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. trimmed its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 16.8% in the first quarter, Holdings Channel.com reports. The institutional investor owned 7,875 shares of the biopharmaceutical company’s stock after selling 1,592 shares during the quarter. Vontobel Holding Ltd.’s holdings in Incyte were worth $477,000 as of its most recent filing […] - 2025-07-08 04:46:50
Sumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)
Sumitomo Mitsui Trust Group Inc. increased its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 5.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 473,186 shares of the biopharmaceutical company’s stock after purchasing an additional 25,844 shares […] - 2025-07-03 05:25:07
Incyte Corporation (NASDAQ:INCY) Shares Purchased by Chevy Chase Trust Holdings LLC
Chevy Chase Trust Holdings LLC raised its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 0.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,241 shares of the biopharmaceutical company’s stock after purchasing an additional 334 shares during the quarter. […] - 2025-06-27 05:36:52
Janney Montgomery Scott LLC Boosts Stock Position in Incyte Corporation (NASDAQ:INCY)
Janney Montgomery Scott LLC grew its stake in Incyte Corporation (NASDAQ:INCY – Free Report) by 10.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 29,793 shares of the biopharmaceutical company’s stock after purchasing an additional 2,746 shares during the period. Janney Montgomery Scott LLC’s holdings in Incyte were worth $1,804,000 as of its […] - 2025-06-27 04:26:49
State of Alaska Department of Revenue Purchases 590 Shares of Incyte Corporation (NASDAQ:INCY)
State of Alaska Department of Revenue lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 3.2% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,824 shares of the biopharmaceutical company’s stock after acquiring an additional 590 shares […] - 2025-06-26 05:56:50
Kentucky Retirement Systems Insurance Trust Fund Makes New Investment in Incyte Corporation (NASDAQ:INCY)
Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Incyte Corporation (NASDAQ:INCY – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 4,624 shares of the biopharmaceutical company’s stock, valued at approximately $280,000. A number […] - 2025-06-26 05:03:09
Incyte Corporation (NASDAQ:INCY) Shares Acquired by Wealth Enhancement Advisory Services LLC
Wealth Enhancement Advisory Services LLC lifted its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 66.5% during the 1st quarter, HoldingsChannel.com reports. The fund owned 79,735 shares of the biopharmaceutical company’s stock after acquiring an additional 31,851 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Incyte were worth $4,828,000 […] - 2025-06-26 04:30:52
Assenagon Asset Management S.A. Has $536,000 Stock Position in Incyte Corporation (NASDAQ:INCY)
Assenagon Asset Management S.A. raised its position in Incyte Corporation (NASDAQ:INCY – Free Report) by 37.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,846 shares of the biopharmaceutical company’s stock after acquiring an additional 2,418 shares during the period. […] - 2025-06-20 04:54:50
Incyte Corporation (NASDAQ:INCY) Shares Sold by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lowered its position in shares of Incyte Corporation (NASDAQ:INCY – Free Report) by 41.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,117 shares of the biopharmaceutical company’s stock after selling 12,867 shares during the period. Exchange Traded Concepts […] - 2025-06-19 05:43:03
Fifth Third Bancorp Has $551,000 Holdings in Incyte Corporation (NASDAQ:INCY)
Fifth Third Bancorp raised its holdings in Incyte Corporation (NASDAQ:INCY – Free Report) by 2.0% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 9,103 shares of the biopharmaceutical company’s stock after acquiring an additional 179 shares during the quarter. Fifth Third Bancorp’s holdings in Incyte were worth $551,000 at the end of […] - 2025-06-18 04:56:49
Incyte (NASDAQ:INCY) Raised to “Buy” at Stifel Nicolaus
Incyte (NASDAQ:INCY – Get Free Report) was upgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “buy” rating in a research report issued on Monday, MarketBeat reports. The brokerage currently has a $107.00 price objective on the biopharmaceutical company’s stock, up from their previous price objective of $75.00. Stifel Nicolaus’ price […] - 2025-06-18 02:22:54
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43

iShares S&P 500 EUR Hedged UCITS ETF (Acc) INCY holdings

DateNumber of INCY Shares HeldBase Market Value of INCY SharesLocal Market Value of INCY SharesChange in INCY Shares HeldChange in INCY Base ValueCurrent Price per INCY Share HeldPrevious Price per INCY Share Held
2025-12-04 (Thursday)23,378USD 2,011,868INCY holding decreased by -22919USD 2,011,8680USD -22,919 USD 86.0582 USD 87.0385
2025-12-03 (Wednesday)23,378USD 2,034,787INCY holding decreased by -8434USD 2,034,7870USD -8,434 USD 87.0385 USD 87.3993
2025-12-02 (Tuesday)23,378INCY holding increased by 70USD 2,043,221INCY holding decreased by -1790USD 2,043,22170USD -1,790 USD 87.3993 USD 87.7386
2025-12-01 (Monday)23,308INCY holding increased by 175USD 2,045,011INCY holding decreased by -37168USD 2,045,011175USD -37,168 USD 87.7386 USD 90.009
2025-11-28 (Friday)23,133INCY holding increased by 35USD 2,082,179INCY holding decreased by -22529USD 2,082,17935USD -22,529 USD 90.009 USD 91.1208
2025-11-27 (Thursday)23,098USD 2,104,708INCY holding decreased by -817USD 2,104,7080USD -817 USD 91.1208 USD 91.1562
2025-11-26 (Wednesday)23,098USD 2,105,525INCY holding decreased by -3010USD 2,105,5250USD -3,010 USD 91.1562 USD 91.2865
2025-11-25 (Tuesday)23,098USD 2,108,535INCY holding decreased by -19859USD 2,108,5350USD -19,859 USD 91.2865 USD 92.1462
2025-11-24 (Monday)23,098INCY holding decreased by -35USD 2,128,394INCY holding increased by 75658USD 2,128,394-35USD 75,658 USD 92.1462 USD 88.7363
2025-11-21 (Friday)23,133INCY holding increased by 35USD 2,052,736INCY holding increased by 13475USD 2,052,73635USD 13,475 USD 88.7363 USD 88.2873
2025-11-20 (Thursday)23,098USD 2,039,261INCY holding increased by 12510USD 2,039,2610USD 12,510 USD 88.2873 USD 87.7457
2025-11-19 (Wednesday)23,098INCY holding decreased by -105USD 2,026,751INCY holding decreased by -54547USD 2,026,751-105USD -54,547 USD 87.7457 USD 89.6995
2025-11-18 (Tuesday)23,203INCY holding decreased by -140USD 2,081,298INCY holding decreased by -15305USD 2,081,298-140USD -15,305 USD 89.6995 USD 89.8172
2025-11-17 (Monday)23,343INCY holding decreased by -70USD 2,096,603INCY holding decreased by -3168USD 2,096,603-70USD -3,168 USD 89.8172 USD 89.684
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INCY by Blackrock for IE00B3ZW0K18

Show aggregate share trades of INCY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY70103.540100.550 100.849USD 7,059 66.59
2025-12-01BUY175103.890101.470 101.712USD 17,800 66.50
2025-11-28BUY35106.990103.850 104.164USD 3,646 66.40
2025-11-24SELL-35106.670102.503 102.920USD -3,602 65.96 Loss of -1,294 on sale
2025-11-21BUY35103.200101.400 101.580USD 3,555 65.86
2025-11-19SELL-105104.660100.300 100.736USD -10,577 65.67 Loss of -3,682 on sale
2025-11-18SELL-140107.265103.790 104.137USD -14,579 65.56 Loss of -5,401 on sale
2025-11-17SELL-70105.970103.830 104.044USD -7,283 65.45 Loss of -2,701 on sale
2025-11-07SELL-70106.400103.810 104.069USD -7,285 64.73 Loss of -2,754 on sale
2025-11-05SELL-245106.470101.500 101.997USD -24,989 64.48 Loss of -9,192 on sale
2025-10-28BUY3591.65093.980 93.747USD 3,281 63.97
2025-10-14SELL-21085.96086.160 86.140USD -18,089 63.36 Loss of -4,783 on sale
2025-10-02BUY7086.28088.660 88.422USD 6,190 63.20
2025-09-30SELL-7084.81085.310 85.260USD -5,968 63.10 Loss of -1,551 on sale
2025-09-16BUY3583.90084.580 84.512USD 2,958 62.84
2025-08-21BUY3586.53086.970 86.926USD 3,042 62.67
2025-08-20SELL-7086.20086.370 86.353USD -6,045 62.61 Loss of -1,662 on sale
2025-08-13BUY7085.85086.020 86.003USD 6,020 62.49
2025-08-12BUY3581.61081.820 81.799USD 2,863 62.45
2025-08-08SELL-3578.39079.000 78.939USD -2,763 62.39 Loss of -579 on sale
2025-08-05BUY7077.72078.500 78.422USD 5,490 62.34
2025-08-04SELL-14078.04078.250 78.229USD -10,952 62.31 Loss of -2,229 on sale
2025-08-01SELL-3575.59075.690 75.680USD -2,649 62.29 Loss of -469 on sale
2025-07-31SELL-5,27174.89077.460 77.203USD -406,937 62.27 Loss of -78,702 on sale
2025-07-30BUY4377.55078.770 78.648USD 3,382 62.24
2025-07-18SELL-13267.86069.430 69.273USD -9,144 62.31 Loss of -919 on sale
2025-07-16SELL-8869.23069.420 69.401USD -6,107 62.34 Loss of -621 on sale
2025-07-10BUY4470.34070.620 70.592USD 3,106 62.42
2025-07-07BUY8867.27068.250 68.152USD 5,997 62.50
2025-07-02BUY4468.17069.100 69.007USD 3,036 62.59
2025-06-24BUY6469.01069.540 69.487USD 4,447 62.71
2025-06-23BUY3267.26068.780 68.628USD 2,196 62.73
2025-06-18BUY3268.27069.470 69.350USD 2,219 62.80
2025-06-17BUY3268.81070.890 70.682USD 2,262 62.82
2025-06-05SELL-6467.24067.870 67.807USD -4,340 62.98 Loss of -309 on sale
2025-06-03BUY6467.11070.970 70.584USD 4,517 63.04
2025-05-28BUY35264.93065.610 65.542USD 23,071 63.20
2025-05-27BUY9665.35065.800 65.755USD 6,312 63.25
2025-05-22SELL-3264.51065.330 65.248USD -2,088 63.40 Loss of -59 on sale
2025-05-21SELL-3264.78065.460 65.392USD -2,093 63.45 Loss of -62 on sale
2025-05-20SELL-6465.30066.110 66.029USD -4,226 63.49 Loss of -162 on sale
2025-05-19SELL-6463.81064.300 64.251USD -4,112 63.55 Loss of -45 on sale
2025-05-15BUY3262.76062.990 62.967USD 2,015 63.66
2025-05-14BUY6461.16062.500 62.366USD 3,991 63.74
2025-05-13BUY9660.81061.150 61.116USD 5,867 63.81
2025-05-12BUY19260.85061.410 61.354USD 11,780 63.89
2025-05-09BUY9658.98060.480 60.330USD 5,792 63.98
2025-05-02BUY3262.53062.870 62.836USD 2,011 64.44
2025-04-28BUY3259.52059.600 59.592USD 1,907 64.83
2025-04-25SELL-3259.16059.210 59.205USD -1,895 64.94 Profit of 184 on sale
2025-04-24BUY9658.97059.050 59.042USD 5,668 65.07
2025-04-23BUY3258.00059.010 58.909USD 1,885 65.20
2025-04-22BUY3257.38058.040 57.974USD 1,855 65.34
2025-04-16SELL-3257.73058.780 58.675USD -1,878 65.91 Profit of 232 on sale
2025-04-15BUY3258.46059.950 59.801USD 1,914 66.06
2025-04-14BUY6459.22059.300 59.292USD 3,795 66.20
2025-04-11BUY6456.87057.070 57.050USD 3,651 66.36
2025-04-10BUY3255.17058.330 58.014USD 1,856 66.53
2025-04-09BUY3258.86059.370 59.319USD 1,898 66.67
2025-04-08BUY6456.97061.470 61.020USD 3,905 66.82
2025-04-07SELL-3260.29061.060 60.983USD -1,951 66.94 Profit of 191 on sale
2025-04-04SELL-19260.58063.570 63.271USD -12,148 67.07 Profit of 729 on sale
2025-04-01SELL-6460.91062.000 61.891USD -3,961 67.29 Profit of 345 on sale
2025-03-31SELL-6460.55060.810 60.784USD -3,890 67.41 Profit of 424 on sale
2025-03-28SELL-6460.60060.970 60.933USD -3,900 67.54 Profit of 423 on sale
2025-03-25BUY3262.08063.270 63.151USD 2,021 67.91
2025-03-21SELL-12861.92062.330 62.289USD -7,973 68.15 Profit of 750 on sale
2025-03-20SELL-9660.58061.750 61.633USD -5,917 68.29 Profit of 639 on sale
2025-03-18BUY19260.00061.030 60.927USD 11,698 68.61
2025-03-11SELL-3268.07071.650 71.292USD -2,281 69.10 Loss of -70 on sale
2025-03-10SELL-9671.13071.890 71.814USD -6,894 69.14 Loss of -257 on sale
2025-03-07SELL-22470.79072.810 72.608USD -16,264 69.20 Loss of -764 on sale
2025-03-05SELL-9669.81069.970 69.954USD -6,716 69.25 Loss of -67 on sale
2025-03-03SELL-12870.26073.450 73.131USD -9,361 69.33 Loss of -487 on sale
2025-02-27SELL-3273.18074.600 74.458USD -2,383 69.30 Loss of -165 on sale
2025-02-19BUY3270.16071.430 71.303USD 2,282 69.28
2025-02-18BUY6471.27071.680 71.639USD 4,585 69.30
2025-02-13BUY6470.01072.690 72.422USD 4,635 69.41
2025-02-05SELL-25675.26075.740 75.692USD -19,377 69.47 Loss of -1,592 on sale
2025-02-04BUY3274.12074.920 74.840USD 2,395 69.44
2025-01-29BUY3273.72074.110 74.071USD 2,370 69.30
2025-01-28BUY3273.15073.990 73.906USD 2,365 69.28
2025-01-24BUY9672.59073.680 73.571USD 7,063 69.29
2025-01-23BUY22472.53072.880 72.845USD 16,317 69.28
2025-01-22BUY16072.41073.550 73.436USD 11,750 69.28
2025-01-21BUY3273.47073.980 73.929USD 2,366 69.24
2025-01-16BUY19272.47072.980 72.929USD 14,002 69.20
2025-01-15BUY3272.46073.830 73.693USD 2,358 69.18
2025-01-10BUY3270.54072.600 72.394USD 2,317 69.12
2024-12-10BUY3272.48073.100 73.038USD 2,337 69.01
2024-12-09BUY12872.11075.980 75.593USD 9,676 69.03
2024-12-05SELL-6474.92075.370 75.325USD -4,821 68.88 Loss of -413 on sale
2024-12-04BUY9674.62075.320 75.250USD 7,224 68.81
2024-12-03SELL-16072.03072.960 72.867USD -11,659 68.82 Loss of -647 on sale
2024-12-02BUY6473.24074.700 74.554USD 4,771 68.78
2024-11-25BUY6473.52073.870 73.835USD 4,725 68.28
2024-11-22SELL-3271.72072.000 71.972USD -2,303 68.25 Loss of -119 on sale
2024-11-21SELL-3270.39071.400 71.299USD -2,282 68.31 Loss of -96 on sale
2024-11-18BUY16076.97077.010 77.006USD 12,321 68.19
2024-11-12BUY3280.58082.020 81.876USD 2,620 67.71
2024-11-08BUY22483.38083.950 83.893USD 18,792 66.37
2024-11-07BUY6482.34082.970 82.907USD 5,306 65.62
2024-11-06BUY3280.95082.190 82.066USD 2,626 64.80
2024-10-31SELL-5,34274.12074.680 74.624USD -398,641 62.35 Loss of -65,551 on sale
2024-10-29BUY4273.60074.070 74.023USD 3,109 60.44
2024-10-28BUY4265.69065.880 65.861USD 2,766 60.38
2024-10-25BUY4265.07065.740 65.673USD 2,758 60.45
2024-10-24BUY4265.24065.910 65.843USD 2,765 60.47
2024-10-23SELL-8465.17066.100 66.007USD -5,545 60.46 Loss of -466 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INCY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19321,923395451,11071.4%
2025-09-18244,9471,423469,74752.1%
2025-09-17277,858779546,95350.8%
2025-09-16359,781946576,37962.4%
2025-09-15347,4534582,22859.7%
2025-09-12353,0400631,53455.9%
2025-09-11448,7333,894739,70160.7%
2025-09-10490,727248671,93273.0%
2025-09-09515,3951,822682,79175.5%
2025-09-08308,184119479,82864.2%
2025-09-05256,7192,505512,04950.1%
2025-09-04422,6241,507834,71750.6%
2025-09-03381,6797,777624,92261.1%
2025-09-02547,12015,396816,26767.0%
2025-08-29148,294262304,42748.7%
2025-08-28164,0080347,48047.2%
2025-08-27248,926453513,40148.5%
2025-08-26365,1306709,32051.5%
2025-08-25478,1301,306642,31974.4%
2025-08-22344,3522,023596,30157.7%
2025-08-21198,7294,881335,30159.3%
2025-08-20351,6993,977555,34563.3%
2025-08-19343,1103,146574,32859.7%
2025-08-18366,1244,996653,10356.1%
2025-08-15480,8858,035625,79776.8%
2025-08-14593,55436,654806,06873.6%
2025-08-13845,18198,1601,257,50367.2%
2025-08-12462,89642,208678,68968.2%
2025-08-11385,211696595,89264.6%
2025-08-08248,925738426,18758.4%
2025-08-07268,864929420,48663.9%
2025-08-06554,642891731,48475.8%
2025-08-05361,6872,092623,87958.0%
2025-08-04338,0051,464519,15065.1%
2025-08-01414,814828572,87972.4%
2025-07-31570,8456,148777,41773.4%
2025-07-30471,30314,166881,19453.5%
2025-07-29966,64010,5811,593,70160.7%
2025-07-28382,23662625,51061.1%
2025-07-25216,96749422,99051.3%
2025-07-24348,27623528,51765.9%
2025-07-23297,903583487,29761.1%
2025-07-22267,987172446,48960.0%
2025-07-21223,626380406,72955.0%
2025-07-18241,218108471,58951.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy